Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
North Carolina death toll reaches 115 as recovery efforts continue
Just In
Panthers lose to Bears 36-10
Just In
Help Helene victims: Click to give money, give blood, donate goods or volunteer â¤ï¸ Here's your guide to help our western NC neighbors
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Ram Mukunda
Recent news which mentions Ram Mukunda
EXCLUSIVE: Revolutionary Alzheimer's Drug By IGC Shows Early Success
March 20, 2024
Tickers
DRUG
IGC
Tags
Ram Mukunda
IGC Pharma
Top Stories
From
Benzinga
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
February 19, 2024
Tickers
IGC
Tags
Earnings
University of Los Andes
Biotech
From
Benzinga
Cannabis Based Pain Relief Solution Receives European Patent Approval
October 20, 2023
Tickers
IGC
Tags
News
General
pain releif
From
Benzinga
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers
POTX
TOKE
Tags
POTX
Benzinga
FDA
From
Benzinga
IGC Pharma FY23 Revenue Grows 129%, What About Net Loss?
July 12, 2023
Tickers
IGC
Tags
Market News
Cannabis
Markets
From
Benzinga
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
February 15, 2023
Tickers
IGC
Tags
Earnings
News
Ram Mukunda
From
Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
January 04, 2023
Tickers
IGC
Tags
News
Cannabis
Markets
From
Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
December 01, 2022
Tickers
IGC
Tags
Market News
Markets
Cannabis
From
Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
November 02, 2022
Tickers
IGC
Tags
News
Earnings
Cannabis
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.